Table 1 Demographic and clinical characteristics of the study subjects.
Total (72) | Recurrence (18) | No recurrence (54) | p value | ||
|---|---|---|---|---|---|
Age (CI 95%) | 40.1 (37.01–43.29) | 39.8 (32.79–46.76) | 40.3 (36.65–43.90) | 0.8919 | |
Gender (%) | Female | 20 (27.8) | 5 (27.8) | 15 (27.8) | 1.0000 |
Male | 52 (72.2) | 13 (72.2) | 39 (72.2) | ||
Ethnicity (%) | White | 16 (22.2) | 4 (22.2) | 12 (22.2) | 1.0000 |
Mixed | 48 (66.7) | 12 (66.7) | 36 (66.7) | ||
Black | 8 (11.1) | 2 (11.1) | 6 (11.1) | ||
Time to first recurrence (in days) (%) | < 60 | – | 6 (33.3) | – | – |
61–120 | – | 8 (44.4) | – | ||
121–180 | – | 4 (22.2) | – | ||
Malaria recurrence (%) | 1 episode | – | 14 (77.8) | – | – |
2 episodes | – | 4 (22.2) | – | ||
Parasite clearance day (%) (n = 71) | 2 | 16 (22.5) | 3 (17.6) | 13 (24.1) | 0.250 |
3 | 32 (45.1) | 6 (35.3) | 26 (48.1) | ||
5 | 22 (31.0) | 7 (41.2) | 15 (27.8) | ||
14 | 1 (1.4) | 1 (5.9) | 0 (0.00) | ||
Gametocyte clearance day (%) (n = 44) | 2 | 14 (31.8) | 2 (16.7) | 12 (37.5) | 0.142 |
3 | 27 (61.4) | 8 (66.7) | 19 (59.4) | ||
5 | 3 (6.8) | 2 (16.7) | 1 (3.1) | ||
